third quarter report new guard anticip
pend upjohn merger
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
regist netherland lead gener drugmak
roughli manufactur facil although compani
form compani posit second-largest gener
compani larg attribut acquisit matrix laboratori
gener busi germany-bas merck kgaa portfolio
gener specialti over-the-count activ
ingredi medicin
manufactur epipen treatment anaphylaxi acquir
merk kgaa transact
predominantli
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim jul
price data
rate updat
currenc amount express
methodolog valu compani
third-quart result came ahead
expect potenti regulatori ration
newco pend merger upjohn top mind
unlik prior earn call investor discuss
predominantli led chairman robert couri support
presid rajiv malik new guard present
transpar top-lin growth larg driven new
product launch emphasi north america
partial off-set declin commod volum
lower global price improv profit north
america segment larg driven new product
launch stabil market initi step
ration unprofit commod
stock-keep unit
locat better-than-expect
result increas full-year ep outlook
toward bottom lower guidanc
rang maintain no-moat rate
fair valu estim pend merger off-
patent brand gener busi upjohn
remedi
total revenu billion grew year year
vast major growth attribut launch two
copd drug wixela yupelri north america
segment grew year year global new
product launch contribut million off-set
impact global price oper margin appear
stabil benefit continu
implement product ration cost-sav
initi despit new drug launch stabil
 gener market expect perform
secondari integr upjohn newco
displac teva largest gener manufactur
expand commerci platform improv foot
under-perform asset increasingli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
